Skip to main content

Table 1 Positivity of mPRα expression in human breast cancers

From: Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway

mPRα reactivity

TNBC

Non TNBC

Total

Positive (%)

13 (92.9)

81 (89)

94(89.5)

Negative

1

10

11

Total

14

91

105

  1. No significant difference was found between the positive rates of mPRα (TNBC vs. non TNBC groups, P = 0.312, Fisher's exact test). MPRα, membrane progesterone receptor α; TNBC, triple-negative cancers.